Læs om Acarix AS | Jobfinder

Digitale medier

ING/
Vi har kvalificeret din tech-viden siden 1892
ING/Version2
Den skarpeste dækning af de vigtigste it-nyheder
ING/Radar
Fordi tech er politisk
ING/Pro
Nicheviden for professionelle
- ING/BuildingTech
  Byggeri, renovering og vedligehold
- ING/CareTech
  Velfærdsteknologi og hjælpemidler
- ING/ComplianceTech
  GDPR og compliance
- ING/DataTech
  Analytics og data
- ING/DigiTech
  Offentlig digitalisering og IT-projekter
- ING/GridTech
  Energi og elektrificering
- ING/MobilityTech
  Transport og trafik
- ING/WasteTech
  Affald og genanvendelse
- ING/WaterTech
  Teknologi og vandets kredsløb
Transformator
Ugentlig podcast med teknologiske nyheder og tendenser

Printmedier

Kommercielt

Om Acarix AS

Acarix is a Danish/Swedish commercial stage medical device company specializing in non-invasive, acoustic rule-out of Coronary Artery Disease (CAD).

Acarix was established in 2009 as a spin-out company from Coloplast A/S. Since 2010 key investors SEED Capital (DK) and Sunstone Life Science Ventures (DK) have financed the development of the company and supported it towards market introduction.

Acarix received CE-approval in 2015 for its CADScor®System, for easy rule-out of coronary artery disease, which is now actively marketed in the Northern European markets.

Since December 2016 the company has been listed on Nasdaq First North Premier in Stockholm.

More info at www.acarix.com